Workflow
Science 37 Quickly Impacts Performance in Under-Enrolling Clinical Trials
Science 37 Science 37 (US:SNCE) Newsfilter·2024-06-27 13:41

Core Insights - Science 37 has been integrated into over 20 studies that were experiencing recruitment delays, helping them to align with their projected enrollment targets [1][2] - The company utilizes its proprietary Virtual Site and Patient Recruitment solutions to efficiently identify, recruit, and enroll patients without geographic limitations [1][6] - Science 37's services are applicable across various therapeutic areas, including Hematology, Hepatology, Infectious Diseases, CNS, Oncology, and Rare Diseases [2][6] Company Overview - Science 37 aims to accelerate clinical research by providing universal trial access for patients through its Metasite™ and Patient Recruitment solutions [6] - The company employs a proprietary technology stack and in-house medical and operational experts to enhance the quality of clinical trials through standardized workflows [6] - Science 37's Patient Recruitment can be utilized independently or in conjunction with its flagship Metasite™ to improve patient enrollment efforts [5][6]